risperidon teva 50 mg prášok a vehikulum na injekčnú suspenziu s predĺženým uvoľňovaním
teva pharmaceuticals slovakia s.r.o., slovensko - risperidón - 68 - antipsychotica (neuroleptica)
risperidon teva 37,5 mg prášok a vehikulum na injekčnú suspenziu s predĺženým uvoľňovaním
teva pharmaceuticals slovakia s.r.o., slovensko - risperidón - 68 - antipsychotica (neuroleptica)
risperidon teva 25 mg prášok a vehikulum na injekčnú suspenziu s predĺženým uvoľňovaním
teva pharmaceuticals slovakia s.r.o., slovensko - risperidón - 68 - antipsychotica (neuroleptica)
egoropal 150 mg
egis pharmaceuticals plc, maďarsko - paliperidón - 68 - antipsychotica (neuroleptica)
egoropal 100 mg
egis pharmaceuticals plc, maďarsko - paliperidón - 68 - antipsychotica (neuroleptica)
egoropal 75 mg
egis pharmaceuticals plc, maďarsko - paliperidón - 68 - antipsychotica (neuroleptica)
egoropal 50 mg
egis pharmaceuticals plc, maďarsko - paliperidón - 68 - antipsychotica (neuroleptica)
egoropal 25 mg
egis pharmaceuticals plc, maďarsko - paliperidón - 68 - antipsychotica (neuroleptica)
imcivree
rhythm pharmaceuticals netherlands b.v. - setmelanotide - obezita - prípravky proti obezite, okrem diétne výrobky - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.
bylvay
albireo - odevixibat - cholestasis, intrahepatic - liečba žlčou a pečeňou - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 a 5.